Mode
Text Size
Log in / Sign up
N/A N=40 Randomized Double-blind Basic Science

Imaging Biomarkers for TMS Treatment of Depression

Depression

Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcome: Primary: Depressive Symptoms at 4 Weeks — 15.6; 15.6 units on a scale — p=0.16

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
repetitive Transcranial Magnetic Stimulation (rTMS) (Device)
Age
Adult, Older Adult · 22+ yrs
Sex
All
Sponsor
University of Michigan
Primary completion
Jan 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Depressive Symptoms at 4 Weeks
15.6; 15.6 0.16
SECONDARY
Depression Symptoms at 4 Weeks- Secondary
9.1; 10.1 0.04 sig

Summary

The purpose of this research is to learn more about how rTMS works to reduce the symptoms of depression. This information can be used to improve the effectiveness of the treatment. The study will use functional magnetic resonance imaging (fMRI) to examine changes in brain function after treatment with rTMS. fMRI is a safe and painless technique that allows investigators to observe the brain "at work." The investigators will use fMRI to see what regions of the brain become active when you perform a concentration task and how that activation is changed after rTMS.

Eligibility Criteria

Inclusion Criteria

  • Primary diagnosis of major depressive disorder
  • Male and female subjects, ages 22-65
  • Have failed at least 1 antidepressant medication at adequate dose and duration
  • On stable antidepressant medication regimen for at least 4 weeks prior to TMS therapy

Exclusion Criteria

  • Diagnosed with a psychotic, bipolar, obsessive-compulsive or post-traumatic stress disorder
  • Active substance abuse, including alcohol
  • Medical and/or neurological condition that could affect your brain function or risk of seizure, including a stroke, epilepsy, or a closed head injury;
  • No presence of an implanted device like a pacemaker/neurostimulator or metal in the head or body;
  • Pregnant or trying to get pregnant
  • Failed to respond to an adequate course of electroconvulsive therapy (ECT)
  • Previous treatment with TMS
  • Current depressive episode longer than 5 years
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01900314). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search